While in general, most reports focus on the protumoral effects of IL-1β in cancer biology, the authors highlighted antitumoral functions of IL-1β as well, raising important considerations for future developments of IL-1 blocking strategies in cancer. The gene discussed is IL1A; the disease is cancer.